Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Turtle Cameron Create: Alert

All | News | Filings
Date FiledTypeDescription
06/30/2023 3 Turtle Cameron (Chief Operating Officer) has filed a Form 3 on Aeglea BioTherapeutics, Inc.
01/28/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/29/2020 4 Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Sold 10,937 shares @ $69.3361, valued at $758.3k
Sold 8,563 shares @ $69.9352, valued at $598.9k
Exercised 7,500 options to buy @ $17, valued at $127.5k
Exercised 6,000 options to buy @ $0.34, valued at $2k
Exercised 6,000 options to buy @ $0.16, valued at $960
12/16/2020 4 Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 3,756 shares @ $110.2906, valued at $414.3k
Sold 7,600 shares @ $111.3075, valued at $845.9k
Sold 11,445 shares @ $112.1903, valued at $1.3M
Sold 3,493 shares @ $112.9657, valued at $394.6k
Exercised 4,451 options to buy @ $17, valued at $75.7k
Exercised 21,843 options to buy @ $13.2, valued at $288.3k
11/25/2020 4 Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Sold 4,258 shares @ $47.0026, valued at $200.1k
Sold 742 shares @ $47.2288, valued at $35k
Exercised 4,258 options to buy @ $17, valued at $72.4k
Exercised 742 options to buy @ $17, valued at $12.6k
11/13/2020 4 Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 3,005 shares @ $73.564, valued at $221.1k
Sold 9,497 shares @ $74.7457, valued at $709.9k
Sold 908 shares @ $75.2286, valued at $68.3k
Gifted 1,500 shares @ $0
11/09/2020 4 Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Sold 2,500 shares @ $42.0499, valued at $105.1k
Exercised 2,500 options to buy @ $17, valued at $42.5k
11/03/2020 4 Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 9,145 shares @ $70.4438, valued at $644.2k
Sold 3,146 shares @ $71.4167, valued at $224.7k
Sold 209 shares @ $72.0961, valued at $15.1k
Exercised 5,000 options to buy @ $13.2, valued at $66k
Exercised 2,500 options to buy @ $17, valued at $42.5k
10/02/2020 4 Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Sold 12,442 shares @ $37.5945, valued at $467.8k
Sold 2,058 shares @ $38.2444, valued at $78.7k
Exercised 2,500 options to buy @ $17, valued at $42.5k
Exercised 6,000 options to buy @ $0.16, valued at $960
Exercised 6,000 options to buy @ $0.34, valued at $2k
09/22/2020 4 Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Sold 2,500 shares @ $42.0097, valued at $105k
Exercised 2,500 options to buy @ $17, valued at $42.5k
09/16/2020 4 Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Sold 2,500 shares @ $37.0607, valued at $92.7k
Exercised 2,500 options to buy @ $17, valued at $42.5k
09/15/2020 4 Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Sold 2,000 shares @ $35.0235, valued at $70k
Exercised 2,000 options to buy @ $0.34, valued at $680
09/11/2020 4 Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 2,500 shares @ $47, valued at $117.5k
Exercised 2,500 options to buy @ $17, valued at $42.5k
09/02/2020 4 Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Granted 2,745 shares @ $0
08/05/2020 4 Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 2,800 shares @ $39.0471, valued at $109.3k
Sold 6,700 shares @ $40.2495, valued at $269.7k
Sold 500 shares @ $40.8927, valued at $20.4k
Exercised 5,000 options to buy @ $13.2, valued at $66k
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/05/2020 4 Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Granted 376 shares @ $41.5735, valued at $15.6k
05/28/2020 4 Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 2,500 shares @ $47, valued at $117.5k
Exercised 2,500 options to buy @ $17, valued at $42.5k
05/21/2020 4 Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Granted 1,082 options to buy @ $1.25, valued at $1.4k
Granted 74,042 options to buy @ $0.16, valued at $11.8k
Granted 49,766 options to buy @ $0.34, valued at $16.9k
05/05/2020 4 Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 7,750 shares @ $40.524, valued at $314.1k
Sold 1,050 shares @ $41.2253, valued at $43.3k
Sold 1,180 shares @ $42.5597, valued at $50.2k
Sold 20 shares @ $43.26, valued at $865.2
Exercised 5,000 options to buy @ $13.2, valued at $66k
04/29/2020 4 Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Sold 2,000 shares @ $32.0138, valued at $64k
Exercised 2,000 options to buy @ $17, valued at $34k
04/10/2020 4 Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Sold 8,000 shares @ $27.0447, valued at $216.4k
Exercised 8,000 options to buy @ $17, valued at $136k
02/13/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2020 4 Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 5,289 shares @ $53.3189, valued at $282k
Sold 7,211 shares @ $53.8949, valued at $388.6k
Exercised 5,000 options to buy @ $13.2, valued at $66k
Exercised 2,500 options to buy @ $17, valued at $42.5k
01/10/2020 4 Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Sold 8,005 shares @ $34.1713, valued at $273.5k
Sold 4,802 shares @ $34.7084, valued at $166.7k
Exercised 10,000 options to buy @ $17, valued at $170k
12/10/2019 4 Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 400 shares @ $56.84, valued at $22.7k
Sold 700 shares @ $58.2771, valued at $40.8k
Sold 8,900 shares @ $59.4294, valued at $528.9k
Exercised 10,000 options to buy @ $13.2, valued at $132k
11/22/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/06/2019 4 Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Sold 4,357 shares @ $41.51, valued at $180.9k
Sold 643 shares @ $42.09, valued at $27.1k
07/03/2019 4 Turtle Cameron (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Exercised 3,368 options to buy @ $0
Exercised 9,262 options to buy @ $0
06/27/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
06/06/2019 4 Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.
Txns: Granted 1,081 shares @ $12.01, valued at $13k
Granted 1,769 shares @ $12.01, valued at $21.2k
Sold 6,700 shares @ $31.33, valued at $209.9k
Sold 3,300 shares @ $32.27, valued at $106.5k
11/07/2018 3 Turtle Cameron (Chief Business Officer) has filed a Form 3 on Eidos Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy